HM
HealthCor Management Portfolio holdings
AUM
$109M
This Quarter Return
+11.63%
1 Year Return
+11.46%
3 Year Return
+50.01%
5 Year Return
+144.68%
10 Year Return
–
AUM
$1.6B
AUM Growth
+$1.6B
(-8.4%)
Cap. Flow
-$336M
Cap. Flow
% of AUM
-20.97%
Top 10 Holdings %
Top 10 Hldgs %
59.97%
Holding
55
New
14
Increased
10
Reduced
9
Closed
20
Top Buys
| 1 |
Cigna
CI
|
$130M |
| 2 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$79.7M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$77.1M |
| 4 |
Eli Lilly
LLY
|
$66.2M |
| 5 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
$61.1M |
Top Sells
| 1 |
AET
Aetna Inc
AET
|
$122M |
| 2 |
Quest Diagnostics
DGX
|
$83.9M |
| 3 |
Hologic
HOLX
|
$81.5M |
| 4 |
Edwards Lifesciences
EW
|
$72.3M |
| 5 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$70.3M |
Sector Composition
| 1 | Healthcare | 90.08% |
| 2 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Quest Diagnostics
DGX
$20.1B
| $13.4M | 0.82% |
158,780
-991,220
| -86% | -$83.9M |
|
|
AGN
27
DELISTED
Allergan plc
AGN
| $13.3M | 0.81% |
+57,550
| New | +$13.3M |
|
28
Medpace
MEDP
$13.5B
| $9.76M | 0.59% |
+326,685
| New | +$9.76M |
|
29
Arbutus Biopharma
ABUS
$753M
| $6.88M | 0.42% |
2,000,000
-258,300
| -11% | -$889K |
|
|
VXX
30
DELISTED
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
| $6.81M | 0.42% |
+200,000
| New | +$6.81M |
|
31
HCA Healthcare
HCA
$95.4B
| $6.79M | 0.41% |
89,740
-168,130
| -65% | -$12.7M |
|
|
SPNE
32
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $6.39M | 0.39% |
632,100
+9,000
| +1% | +$91K |
|
33
AMN Healthcare
AMN
$760M
| $4.22M | 0.26% |
+132,481
| New | +$4.22M |
|
34
Natera
NTRA
$23B
| $3.28M | 0.2% |
294,800
+4,200
| +1% | +$46.7K |
|
35
Align Technology
ALGN
$9.59B
| – | – |
-41,730
| Closed | -$3.36M |
|
36
BioMarin Pharmaceuticals
BMRN
$11.3B
| – | – |
-750,000
| Closed | -$58.4M |
|
37
Bristol-Myers Squibb
BMY
$96.7B
| – | – |
-211,940
| Closed | -$15.6M |
|
38
CVS Health
CVS
$93B
| – | – |
-237,830
| Closed | -$22.8M |
|
39
DexCom
DXCM
$30.9B
| – | – |
-396,030
| Closed | -$31.4M |
|
40
Gilead Sciences
GILD
$140B
| – | – |
-270,680
| Closed | -$22.6M |
|
41
Humana
HUM
$37.5B
| – | – |
-214,920
| Closed | -$38.7M |
|
42
Icon
ICLR
$14B
| – | – |
-475,000
| Closed | -$33.3M |
|
43
Neurocrine Biosciences
NBIX
$13.5B
| – | – |
-450,000
| Closed | -$20.5M |
|
44
Revvity
RVTY
$9.68B
| – | – |
-582,500
| Closed | -$30.5M |
|
45
Thermo Fisher Scientific
TMO
$183B
| – | – |
-233,245
| Closed | -$34.5M |
|
46
Universal Health Services
UHS
$11.6B
| – | – |
-243,490
| Closed | -$32.7M |
|
47
Waters Corp
WAT
$17.3B
| – | – |
-95,530
| Closed | -$13.4M |
|
|
WBA
48
DELISTED
Walgreens Boots Alliance
WBA
| – | – |
-496,680
| Closed | -$41.4M |
|
|
HSTO
49
DELISTED
Histogen Inc. Common Stock
HSTO
| – | – |
-1,059,200
| Closed | -$2.18M |
|
|
HRC
50
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| – | – |
-815,603
| Closed | -$41.1M |
|